American National Bank & Trust’s SpringWorks Therapeutics SWTX Stock Holding History

American National Bank & Trust’s Portfolio SWTX Stock Details SWTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-3	Closed	-$141	–	699
2025 Q2	$141	Buy	+3	New	+$133	﹤0.01%	643

Other funds holding SWTX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

American National Bank & Trust's SWTX Position: Q3 2025 in Review

American National Bank & Trust sold out of SpringWorks Therapeutics (SWTX) in Q3 2025, closing a stake of 3 shares — an estimated $141 sold.

American National Bank & Trust first reported a position in SWTX in Q2 2025 and held it in 1 quarter. The position peaked at $141 in Q2 2025. 3 funds tracked by Wall St. Rank hold SWTX as of Q3 2025.

American National Bank & Trust reported no remaining SpringWorks Therapeutics position as of Q3 2025 after selling out during the quarter.
American National Bank & Trust sold 3 SpringWorks Therapeutics shares in Q3 2025, an estimated $141.
American National Bank & Trust first reported a position in SpringWorks Therapeutics in Q2 2025 and held it in 1 quarter.
American National Bank & Trust's SpringWorks Therapeutics position peaked at $141 in Q2 2025.
3 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q3 2025.

Based on American National Bank & Trust's 13F filing for Q3 2025, filed 21 Oct 2025.